Job Description
This application is for a 6-month student role from January - June 2023. Resume review begins in October 2022.
The Gene Therapy Accelerator Unit (GTxAU) represents Biogen’s center of expertise to develop next-generation gene therapies based on Adeno-Associated vectors. Our mission is to support Biogen’s rapidly growing gene therapy pipeline to treat currently untreatable neurodegenerative, neuroinflammatory, and ophthalmologic disorders. We work to achieve this mission by engineering and validating pre-clinical & clinical candidates and developing new technologies to improve efficacy, safety, and manufacturing processes.
We are looking for highly motivated individuals to join the GTxAU. The position represents an exciting opportunity to gain hands-on experience in the fast-growing gene therapy field.
POSITION DESCRIPTION
As a co-op, you will support exploratory and pipeline projects. Day-to-day responsibilities can include performing wet-lab molecular biology, cell/tissue culture, immunoassays, and characterization of vectors by PCR and western blot. In addition, you should be able to assist with data analysis and interpretation, maintain accurate electronic records and effectively present their work at team meetings. Projects could include: (1) AAV capsid engineering activities, (2) support investigation into immune responses to gene therapy, or (3) evaluate gene therapy vector performance in retinal cell types. Additional bioengineering-based projects are available, where computational and programming skills can be applied.
Qualifications
To participate in the Biogen Internship Program, students must meet the following eligibility criteria:
Additional qualifications for the role:
EDUCATION
BSc/MS in Biology, Biotechnology, Biochemistry, Bioengineering, Pharmacology, Pharmacy, Genetics, Chemical Engineering, or related scientific disciplines
Additional Information
All your information will be kept confidential according to EEO guidelines.